09/12/2025
3:45 PM | Keros Therapeutics (Subject)
Rovaldi Christopher (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2025
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2025
3:10 PM | Keros Therapeutics (Issuer)
Seehra Jasbir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2025
3:15 PM | ADAR1 Capital Management, LLC (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
08/20/2025
8:50 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2025
3:32 PM | Cho Esther (Reporting)
Keros Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2025
3:34 PM | Keros Therapeutics (Issuer)
Lerner Lorena Raquel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2025
7:03 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2025
3:05 PM | ADAR1 Capital Management GP, LLC (Reporting)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Keros Therapeutics (Issuer)
Schneeberger Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:51 PM | ADAR1 Capital Management GP, LLC (Reporting)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Keros Therapeutics (Issuer)
Schneeberger Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
6:45 AM | Kariv Tomer (Reporting)
Keros Therapeutics (Issuer)
| Form 4/A | |
|
06/11/2025
6:30 AM | Keros Therapeutics (Issuer)
Nussbaum Ran (Reporting)
| Form 4/A | |
06/09/2025
5:56 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
3:15 PM | BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:15 PM | GRAY MARY ANN (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:15 PM | Keros Therapeutics (Issuer)
Seth Alpna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:15 PM | Keros Therapeutics (Issuer)
Nussbaum Ran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:15 PM | Kariv Tomer (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:15 PM | Farzan Nima (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:15 PM | GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:15 PM | Keros Therapeutics (Issuer)
Knowles Julius (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
5:58 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/27/2025
12:49 PM | Keros Therapeutics (Filer)
| Form DEFA14A | |
05/19/2025
7:00 AM | Keros Therapeutics (Filer)
| Form DEFA14A | |
05/19/2025
7:01 AM | Keros Therapeutics (Filer)
| Form DEFA14A | |
05/19/2025
7:02 AM | Keros Therapeutics (Filer)
| Form DEFA14A | |
05/14/2025
4:49 PM | Keros Therapeutics (Subject)
Madison Avenue Partners, LP (Filed by)
| Form SCHEDULE 13G | |
05/12/2025
10:29 AM | ADAR1 Capital Management, LLC (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
05/12/2025
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
1:03 PM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/02/2025
8:59 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13G | |
04/30/2025
10:23 AM | Keros Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
04/28/2025
5:43 PM | ADAR1 Capital Management, LLC (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
04/23/2025
3:09 PM | Keros Therapeutics (Filer)
| Form ARS | |
04/23/2025
3:03 PM | Keros Therapeutics (Filer)
| Form DEF 14A | |
04/11/2025
8:57 PM | ADAR1 Capital Management GP, LLC (Reporting)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Keros Therapeutics (Issuer)
Schneeberger Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
7:58 PM | ADAR1 Capital Management GP, LLC (Reporting)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Keros Therapeutics (Issuer)
Schneeberger Daniel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2025
7:32 PM | ADAR1 Capital Management, LLC (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13D | |
04/10/2025
5:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
5:04 AM | Keros Therapeutics (Filer)
| Form 8-A12B | |
04/07/2025
3:15 PM | Keros Therapeutics (Issuer)
Seehra Jasbir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/31/2025
5:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
4:01 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
9:23 AM | FMR LLC (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/30/2025
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
3:15 PM | Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
| Form 4/A | |
01/21/2025
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
5:31 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
7:00 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
5:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
6:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:18 PM | CHYUNG YUNG H. (Reporting)
Keros Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
3:22 PM | Keros Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
7:00 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
